Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

To fight off compounding pharmacies, Eli Lilly wants access to medical records of patients who used copycat products.

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

Cantor Fitzgerald Managing Director Louise Chen noted that price of weight loss drugs from Novo Nordisk and Eli Lilly should ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

New public and private entrants are emerging to challenge the leading positions of Novo Nordisk NVO and Eli Lilly LLY in ...

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

A key study used in securing FDA approval for Wegovy as a lifetime medication for weight loss was based on patients using the ...

The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...

Eli Lilly (NYSE: LLY) is one of the world's top ... I'm talking about Lilly's weight loss drugs, which are bringing in billions of dollars in revenue. Lilly sells the compound tirzepatide in ...

Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...